UNSPSC 51263312: Tolboxane

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C14H21BO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33P8JV23L7, chemically known as 1,3,2-dioxaborinane, 5-methyl-5-propyl-2-p-tolyl- but generally known as tolboxane, which bears US NIH Compound Identifier 72134. European Medicines Agency schedules Tolboxane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11149MIG.

UNSPSC 51263312 Tolboxane (Commodity) does not align with the recent state and local opportunities tagged under this code. The two posted solicitations involve naloxone procurement and pharmaceutical direct-to-manufacturer prescription programs, neither of which fall within the scope of tolboxane, a pharmaceutical compound used in specific therapeutic contexts. The source shows a classification mismatch rather than active market demand for the tolboxane commodity itself.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, and the Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription programs serving self-insured employee group health plans and state agencies. Neither opportunity represents procurement of tolboxane. The tagging appears to reflect a data classification error rather than genuine demand under this commodity code. No recent opportunities supporting tolboxane procurement were identified in the source.